Apollo Therapeutics Ltd

This study is testing a new vaccine called APL-10456 to see if it is safe and can protect against rhinovirus, the main cause of the common cold. About 144 healthy volunteers, split into younger (18-54) and older (55+) groups, will receive either the vaccine or a placebo. The goal…

This early-stage study tests an experimental drug called APL-4098, alone or with standard chemotherapy drugs, in about 100 adults with acute myeloid leukemia (AML) or related blood cancers that have come back or not responded to treatment. The main goals are to check safety, find…

This study tests an experimental drug called APL-9796, given as injections under the skin, for people with pulmonary hypertension (high blood pressure in the lungs). The trial will include up to 48 adults and aims to check the drug's safety, how well it works, and whether the bod…

This study tests a new drug called APL-5125 in about 100 adults with advanced solid tumors, including colorectal, pancreatic, and ovarian cancers. The goal is to check safety and see if the drug can shrink tumors. Participants must have tried standard treatments first.